Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Defining the “Why” in Virtual Team Settings – Building Company Culture Virtually

    January 16, 2025 | Impetus Digital, Pharma tips, Pharma trends, Remote work, Virtual company culture, company culture, home office, pharma 2025, pharma culture, pharma office, top ten tips, work from home 

    Defining your team’s purpose in a virtual setting is crucial for success. Are your workflows clear and documentation accessible? Learn how these elements can transform team dynamics and boost productivity, laying the foundation for a strong virtual workplace.

    In the third video of our series on creating company culture in a virtual environment, we explore the importance of defining your team’s new “why” in the digital workspace. Learn how clear workflows and accessible documentation can solidify team unity and enhance productivity.

    3. Determine the Team’s New “Why” in the Virtual World Understanding and articulating the “why” behind your team’s operations in a virtual setting is crucial. Learn how team leaders can develop a robust framework and foundation that dictates how the team will function and collaborate effectively online. Spending time to clearly define these workflows and ensure that documentation is easily accessible will not only streamline processes but also strengthen the team’s commitment and clarity of purpose. By establishing these guidelines early, teams can enjoy long-term benefits, resulting in a more cohesive and productive virtual work environment.

    For additional resources on enhancing virtual team dynamics and to learn from our expertise in managing remote teams, visit our blog: https://www.impetusdigital.com/2020/11/03/top-10-tips-for-creating-company-culture/

    Enhance your leadership in virtual settings with Impetus Digital:

    Stay connected for more insights on fostering a positive virtual work culture:

    This content was provided by Impetus Digital

    Company Details

    - PMLiVE

    Impetus Digital

    Email
    Website

     Latest Content from  Impetus Digital 

    Digital technologies: Pharma’s answer to achieving net zero emissions?

    As I wrote about earlier this year, it is clear that the climate crisis is no longer something for future generations to worry about, it’s already here and requires our urgent...

    The Real-Time Health System: Accelerating Workflows with Data

    Bree Bush, Vice President, Chief Data Officer at GE Healthcare, dives into simulation modeling and advanced analytical tools to optimize inpatient, procedural, and clinic capacity; the concept of “real-time healthcare”;...

    The Future of eHealth: Contactless Health Monitoring

    Laurence Pearce, CEO & Founder of Xim Ltd, creators of Lifelight®, discusses the need for personal health monitoring; traditional issues associated with population health screening; AI, machine learning, and computer...

    Making Digital Trust and Privacy Accessible to Everyone

    Mike Cook, CEO of IDENTOS, shares how his company is making digital trust and privacy accessible for patients, healthcare providers, payers, organizations, and connected devices. He also discusses “smart cities”...

    Disrupting Cell Engineering with Non-Viral Modalities

    Jessica Schwaber, Scientific Director, Cell & Gene Therapy, Avectas, explores her company’s unique cell engineering platform, the recent shift in cell & gene therapy commercial needs, current barriers to realizing...

    Congress eHuddle & Debrief Session: A Customer Story

    How a Pharma team hosted daily MSL “eHuddles” during ASCO 2021 plus a post-congress debrief session using our asynchronous platform.

    Healthcare Access and Payment Reform in the US

    Chris Saxman, Senior Healthcare Executive, Head of Product Strategy at UCM Digital Health, shares his thoughts on the US healthcare system, including its flaws and how to fix it; the...

    Advancing Drug Discovery with Structured and Intelligent Data

    Michael Wilson and Craig Knox, co-founders of DrugBank, discuss how their comprehensive drug database can be used together with AI and machine learning for drug discovery and repurposing, clinical research,...

    Digitalizing Muskuloskeletal Care to Improve Patient Outcomes and Reduce Cost

    Lydia Zeller, CEO at Kiio, explores digital therapeutics, healthcare innovation, and Kiio’s innovative and personalized solutions for musculoskeletal (MSK) pain. She also shares her key leadership lessons and predictions for...

    Accelerating Drug Development Timelines with Big Data Analytics

    Barış Erdoğan, CEO of Clinerion, shares how medical data informatics and real-world EHR data can be used to improve the efficiency and effectiveness of patient searches, identification, and recruitment; clinical...